The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pulmonary Administration Market Research Report 2025
Synopsis
Pulmonary drug delivery system is a drug delivery route that directly delivers drugs to the respiratory tract and lungs. It is mainly used to treat respiratory diseases, such as asthma, COPD and lung cancer. This method of administration has the advantages of rapid onset, good efficacy, and reduced adverse reactions.
The global Pulmonary Administration market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Pulmonary Administration is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pulmonary Administration is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Pulmonary Administration include Aptar Pharma, Nemera, Porex, Chiesi Farmaceutici, AstraZeneca, H&T Presspart, Gerresheimer, Merxin Ltd, 3M, Aerogen Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pulmonary Administration, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pulmonary Administration.
The Pulmonary Administration market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Pulmonary Administration market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pulmonary Administration manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Aptar Pharma
Nemera
Porex
Chiesi Farmaceutici
AstraZeneca
H&T Presspart
Gerresheimer
Merxin Ltd
3M
Aerogen Pharma
MedPharm
Kindeva Drug Delivery
Boehringer Ingelheim
Chiesi Farmaceutici SpA
Merck & Co, Inc
Novartis AG
PARI international
Vectura Group Plc
GlaxoSmithKline
Koninklijke Philips NV
OMRON Corporation
Sunovion Pharmaceuticals, Inc
Teva Pharmaceutical Industries Ltd
Yisuo Intelligent
Segment by Type
Pressurized Metered Dose Inhalation System
Dry Powder Inhalation System
Soft Mist Inhalation System
Others
Segment by Application
Bronchial Asthma
Chronic Obstructive Pulmonary Disease
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pulmonary Administration manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pulmonary Administration in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Pulmonary drug delivery system is a drug delivery route that directly delivers drugs to the respiratory tract and lungs. It is mainly used to treat respiratory diseases, such as asthma, COPD and lung cancer. This method of administration has the advantages of rapid onset, good efficacy, and reduced adverse reactions.
The global Pulmonary Administration market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Pulmonary Administration is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pulmonary Administration is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Pulmonary Administration include Aptar Pharma, Nemera, Porex, Chiesi Farmaceutici, AstraZeneca, H&T Presspart, Gerresheimer, Merxin Ltd, 3M, Aerogen Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pulmonary Administration, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pulmonary Administration.
The Pulmonary Administration market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Pulmonary Administration market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pulmonary Administration manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Aptar Pharma
Nemera
Porex
Chiesi Farmaceutici
AstraZeneca
H&T Presspart
Gerresheimer
Merxin Ltd
3M
Aerogen Pharma
MedPharm
Kindeva Drug Delivery
Boehringer Ingelheim
Chiesi Farmaceutici SpA
Merck & Co, Inc
Novartis AG
PARI international
Vectura Group Plc
GlaxoSmithKline
Koninklijke Philips NV
OMRON Corporation
Sunovion Pharmaceuticals, Inc
Teva Pharmaceutical Industries Ltd
Yisuo Intelligent
Segment by Type
Pressurized Metered Dose Inhalation System
Dry Powder Inhalation System
Soft Mist Inhalation System
Others
Segment by Application
Bronchial Asthma
Chronic Obstructive Pulmonary Disease
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pulmonary Administration manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pulmonary Administration in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pulmonary Administration Market Overview
1.1 Product Definition
1.2 Pulmonary Administration by Type
1.2.1 Global Pulmonary Administration Market Value Comparison by Type (2024-2030)
1.2.2 Pressurized Metered Dose Inhalation System
1.2.3 Dry Powder Inhalation System
1.2.4 Soft Mist Inhalation System
1.2.5 Others
1.3 Pulmonary Administration by Application
1.3.1 Global Pulmonary Administration Market Value by Application (2024-2030)
1.3.2 Bronchial Asthma
1.3.3 Chronic Obstructive Pulmonary Disease
1.3.4 Others
1.4 Global Pulmonary Administration Market Size Estimates and Forecasts
1.4.1 Global Pulmonary Administration Revenue 2019-2030
1.4.2 Global Pulmonary Administration Sales 2019-2030
1.4.3 Global Pulmonary Administration Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pulmonary Administration Market Competition by Manufacturers
2.1 Global Pulmonary Administration Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pulmonary Administration Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pulmonary Administration Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Pulmonary Administration, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pulmonary Administration, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pulmonary Administration, Product Type & Application
2.7 Global Key Manufacturers of Pulmonary Administration, Date of Enter into This Industry
2.8 Global Pulmonary Administration Market Competitive Situation and Trends
2.8.1 Global Pulmonary Administration Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pulmonary Administration Players Market Share by Revenue
2.8.3 Global Pulmonary Administration Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pulmonary Administration Market Scenario by Region
3.1 Global Pulmonary Administration Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pulmonary Administration Sales by Region: 2019-2030
3.2.1 Global Pulmonary Administration Sales by Region: 2019-2024
3.2.2 Global Pulmonary Administration Sales by Region: 2025-2030
3.3 Global Pulmonary Administration Revenue by Region: 2019-2030
3.3.1 Global Pulmonary Administration Revenue by Region: 2019-2024
3.3.2 Global Pulmonary Administration Revenue by Region: 2025-2030
3.4 North America Pulmonary Administration Market Facts & Figures by Country
3.4.1 North America Pulmonary Administration Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pulmonary Administration Sales by Country (2019-2030)
3.4.3 North America Pulmonary Administration Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pulmonary Administration Market Facts & Figures by Country
3.5.1 Europe Pulmonary Administration Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pulmonary Administration Sales by Country (2019-2030)
3.5.3 Europe Pulmonary Administration Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pulmonary Administration Market Facts & Figures by Region
3.6.1 Asia Pacific Pulmonary Administration Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pulmonary Administration Sales by Region (2019-2030)
3.6.3 Asia Pacific Pulmonary Administration Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pulmonary Administration Market Facts & Figures by Country
3.7.1 Latin America Pulmonary Administration Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pulmonary Administration Sales by Country (2019-2030)
3.7.3 Latin America Pulmonary Administration Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pulmonary Administration Market Facts & Figures by Country
3.8.1 Middle East and Africa Pulmonary Administration Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pulmonary Administration Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pulmonary Administration Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pulmonary Administration Sales by Type (2019-2030)
4.1.1 Global Pulmonary Administration Sales by Type (2019-2024)
4.1.2 Global Pulmonary Administration Sales by Type (2025-2030)
4.1.3 Global Pulmonary Administration Sales Market Share by Type (2019-2030)
4.2 Global Pulmonary Administration Revenue by Type (2019-2030)
4.2.1 Global Pulmonary Administration Revenue by Type (2019-2024)
4.2.2 Global Pulmonary Administration Revenue by Type (2025-2030)
4.2.3 Global Pulmonary Administration Revenue Market Share by Type (2019-2030)
4.3 Global Pulmonary Administration Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pulmonary Administration Sales by Application (2019-2030)
5.1.1 Global Pulmonary Administration Sales by Application (2019-2024)
5.1.2 Global Pulmonary Administration Sales by Application (2025-2030)
5.1.3 Global Pulmonary Administration Sales Market Share by Application (2019-2030)
5.2 Global Pulmonary Administration Revenue by Application (2019-2030)
5.2.1 Global Pulmonary Administration Revenue by Application (2019-2024)
5.2.2 Global Pulmonary Administration Revenue by Application (2025-2030)
5.2.3 Global Pulmonary Administration Revenue Market Share by Application (2019-2030)
5.3 Global Pulmonary Administration Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Aptar Pharma
6.1.1 Aptar Pharma Company Information
6.1.2 Aptar Pharma Description and Business Overview
6.1.3 Aptar Pharma Pulmonary Administration Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Aptar Pharma Pulmonary Administration Product Portfolio
6.1.5 Aptar Pharma Recent Developments/Updates
6.2 Nemera
6.2.1 Nemera Company Information
6.2.2 Nemera Description and Business Overview
6.2.3 Nemera Pulmonary Administration Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Nemera Pulmonary Administration Product Portfolio
6.2.5 Nemera Recent Developments/Updates
6.3 Porex
6.3.1 Porex Company Information
6.3.2 Porex Description and Business Overview
6.3.3 Porex Pulmonary Administration Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Porex Pulmonary Administration Product Portfolio
6.3.5 Porex Recent Developments/Updates
6.4 Chiesi Farmaceutici
6.4.1 Chiesi Farmaceutici Company Information
6.4.2 Chiesi Farmaceutici Description and Business Overview
6.4.3 Chiesi Farmaceutici Pulmonary Administration Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chiesi Farmaceutici Pulmonary Administration Product Portfolio
6.4.5 Chiesi Farmaceutici Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Company Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Pulmonary Administration Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AstraZeneca Pulmonary Administration Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 H&T Presspart
6.6.1 H&T Presspart Company Information
6.6.2 H&T Presspart Description and Business Overview
6.6.3 H&T Presspart Pulmonary Administration Sales, Revenue and Gross Margin (2019-2024)
6.6.4 H&T Presspart Pulmonary Administration Product Portfolio
6.6.5 H&T Presspart Recent Developments/Updates
6.7 Gerresheimer
6.7.1 Gerresheimer Company Information
6.7.2 Gerresheimer Description and Business Overview
6.7.3 Gerresheimer Pulmonary Administration Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Gerresheimer Pulmonary Administration Product Portfolio
6.7.5 Gerresheimer Recent Developments/Updates
6.8 Merxin Ltd
6.8.1 Merxin Ltd Company Information
6.8.2 Merxin Ltd Description and Business Overview
6.8.3 Merxin Ltd Pulmonary Administration Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Merxin Ltd Pulmonary Administration Product Portfolio
6.8.5 Merxin Ltd Recent Developments/Updates
6.9 3M
6.9.1 3M Company Information
6.9.2 3M Description and Business Overview
6.9.3 3M Pulmonary Administration Sales, Revenue and Gross Margin (2019-2024)
6.9.4 3M Pulmonary Administration Product Portfolio
6.9.5 3M Recent Developments/Updates
6.10 Aerogen Pharma
6.10.1 Aerogen Pharma Company Information
6.10.2 Aerogen Pharma Description and Business Overview
6.10.3 Aerogen Pharma Pulmonary Administration Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Aerogen Pharma Pulmonary Administration Product Portfolio
6.10.5 Aerogen Pharma Recent Developments/Updates
6.11 MedPharm
6.11.1 MedPharm Company Information
6.11.2 MedPharm Description and Business Overview
6.11.3 MedPharm Pulmonary Administration Sales, Revenue and Gross Margin (2019-2024)
6.11.4 MedPharm Pulmonary Administration Product Portfolio
6.11.5 MedPharm Recent Developments/Updates
6.12 Kindeva Drug Delivery
6.12.1 Kindeva Drug Delivery Company Information
6.12.2 Kindeva Drug Delivery Description and Business Overview
6.12.3 Kindeva Drug Delivery Pulmonary Administration Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Kindeva Drug Delivery Pulmonary Administration Product Portfolio
6.12.5 Kindeva Drug Delivery Recent Developments/Updates
6.13 Boehringer Ingelheim
6.13.1 Boehringer Ingelheim Company Information
6.13.2 Boehringer Ingelheim Description and Business Overview
6.13.3 Boehringer Ingelheim Pulmonary Administration Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Boehringer Ingelheim Pulmonary Administration Product Portfolio
6.13.5 Boehringer Ingelheim Recent Developments/Updates
6.14 Chiesi Farmaceutici SpA
6.14.1 Chiesi Farmaceutici SpA Company Information
6.14.2 Chiesi Farmaceutici SpA Description and Business Overview
6.14.3 Chiesi Farmaceutici SpA Pulmonary Administration Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Chiesi Farmaceutici SpA Pulmonary Administration Product Portfolio
6.14.5 Chiesi Farmaceutici SpA Recent Developments/Updates
6.15 Merck & Co, Inc
6.15.1 Merck & Co, Inc Company Information
6.15.2 Merck & Co, Inc Description and Business Overview
6.15.3 Merck & Co, Inc Pulmonary Administration Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Merck & Co, Inc Pulmonary Administration Product Portfolio
6.15.5 Merck & Co, Inc Recent Developments/Updates
6.16 Novartis AG
6.16.1 Novartis AG Company Information
6.16.2 Novartis AG Description and Business Overview
6.16.3 Novartis AG Pulmonary Administration Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Novartis AG Pulmonary Administration Product Portfolio
6.16.5 Novartis AG Recent Developments/Updates
6.17 PARI international
6.17.1 PARI international Company Information
6.17.2 PARI international Description and Business Overview
6.17.3 PARI international Pulmonary Administration Sales, Revenue and Gross Margin (2019-2024)
6.17.4 PARI international Pulmonary Administration Product Portfolio
6.17.5 PARI international Recent Developments/Updates
6.18 Vectura Group Plc
6.18.1 Vectura Group Plc Company Information
6.18.2 Vectura Group Plc Description and Business Overview
6.18.3 Vectura Group Plc Pulmonary Administration Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Vectura Group Plc Pulmonary Administration Product Portfolio
6.18.5 Vectura Group Plc Recent Developments/Updates
6.19 GlaxoSmithKline
6.19.1 GlaxoSmithKline Company Information
6.19.2 GlaxoSmithKline Description and Business Overview
6.19.3 GlaxoSmithKline Pulmonary Administration Sales, Revenue and Gross Margin (2019-2024)
6.19.4 GlaxoSmithKline Pulmonary Administration Product Portfolio
6.19.5 GlaxoSmithKline Recent Developments/Updates
6.20 Koninklijke Philips NV
6.20.1 Koninklijke Philips NV Company Information
6.20.2 Koninklijke Philips NV Description and Business Overview
6.20.3 Koninklijke Philips NV Pulmonary Administration Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Koninklijke Philips NV Pulmonary Administration Product Portfolio
6.20.5 Koninklijke Philips NV Recent Developments/Updates
6.21 OMRON Corporation
6.21.1 OMRON Corporation Company Information
6.21.2 OMRON Corporation Description and Business Overview
6.21.3 OMRON Corporation Pulmonary Administration Sales, Revenue and Gross Margin (2019-2024)
6.21.4 OMRON Corporation Pulmonary Administration Product Portfolio
6.21.5 OMRON Corporation Recent Developments/Updates
6.22 Sunovion Pharmaceuticals, Inc
6.22.1 Sunovion Pharmaceuticals, Inc Company Information
6.22.2 Sunovion Pharmaceuticals, Inc Description and Business Overview
6.22.3 Sunovion Pharmaceuticals, Inc Pulmonary Administration Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Sunovion Pharmaceuticals, Inc Pulmonary Administration Product Portfolio
6.22.5 Sunovion Pharmaceuticals, Inc Recent Developments/Updates
6.23 Teva Pharmaceutical Industries Ltd
6.23.1 Teva Pharmaceutical Industries Ltd Company Information
6.23.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.23.3 Teva Pharmaceutical Industries Ltd Pulmonary Administration Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Teva Pharmaceutical Industries Ltd Pulmonary Administration Product Portfolio
6.23.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.24 Yisuo Intelligent
6.24.1 Yisuo Intelligent Company Information
6.24.2 Yisuo Intelligent Description and Business Overview
6.24.3 Yisuo Intelligent Pulmonary Administration Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Yisuo Intelligent Pulmonary Administration Product Portfolio
6.24.5 Yisuo Intelligent Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pulmonary Administration Industry Chain Analysis
7.2 Pulmonary Administration Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pulmonary Administration Production Mode & Process
7.4 Pulmonary Administration Sales and Marketing
7.4.1 Pulmonary Administration Sales Channels
7.4.2 Pulmonary Administration Distributors
7.5 Pulmonary Administration Customers
8 Pulmonary Administration Market Dynamics
8.1 Pulmonary Administration Industry Trends
8.2 Pulmonary Administration Market Drivers
8.3 Pulmonary Administration Market Challenges
8.4 Pulmonary Administration Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Pulmonary Administration Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Pulmonary Administration Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Pulmonary Administration Market Competitive Situation by Manufacturers in 2023
Table 4. Global Pulmonary Administration Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Pulmonary Administration Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Pulmonary Administration Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Pulmonary Administration Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Pulmonary Administration Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Pulmonary Administration, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pulmonary Administration, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pulmonary Administration, Product Type & Application
Table 12. Global Key Manufacturers of Pulmonary Administration, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pulmonary Administration by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Administration as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pulmonary Administration Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Pulmonary Administration Sales by Region (2019-2024) & (K Units)
Table 18. Global Pulmonary Administration Sales Market Share by Region (2019-2024)
Table 19. Global Pulmonary Administration Sales by Region (2025-2030) & (K Units)
Table 20. Global Pulmonary Administration Sales Market Share by Region (2025-2030)
Table 21. Global Pulmonary Administration Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Pulmonary Administration Revenue Market Share by Region (2019-2024)
Table 23. Global Pulmonary Administration Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Pulmonary Administration Revenue Market Share by Region (2025-2030)
Table 25. North America Pulmonary Administration Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Pulmonary Administration Sales by Country (2019-2024) & (K Units)
Table 27. North America Pulmonary Administration Sales by Country (2025-2030) & (K Units)
Table 28. North America Pulmonary Administration Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Pulmonary Administration Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Pulmonary Administration Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Pulmonary Administration Sales by Country (2019-2024) & (K Units)
Table 32. Europe Pulmonary Administration Sales by Country (2025-2030) & (K Units)
Table 33. Europe Pulmonary Administration Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Pulmonary Administration Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Pulmonary Administration Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Pulmonary Administration Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Pulmonary Administration Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Pulmonary Administration Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Pulmonary Administration Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pulmonary Administration Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Pulmonary Administration Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Pulmonary Administration Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Pulmonary Administration Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pulmonary Administration Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Pulmonary Administration Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Pulmonary Administration Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Pulmonary Administration Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Pulmonary Administration Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Pulmonary Administration Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Pulmonary Administration Sales (K Units) by Type (2019-2024)
Table 51. Global Pulmonary Administration Sales (K Units) by Type (2025-2030)
Table 52. Global Pulmonary Administration Sales Market Share by Type (2019-2024)
Table 53. Global Pulmonary Administration Sales Market Share by Type (2025-2030)
Table 54. Global Pulmonary Administration Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Pulmonary Administration Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Pulmonary Administration Revenue Market Share by Type (2019-2024)
Table 57. Global Pulmonary Administration Revenue Market Share by Type (2025-2030)
Table 58. Global Pulmonary Administration Price (US$/Unit) by Type (2019-2024)
Table 59. Global Pulmonary Administration Price (US$/Unit) by Type (2025-2030)
Table 60. Global Pulmonary Administration Sales (K Units) by Application (2019-2024)
Table 61. Global Pulmonary Administration Sales (K Units) by Application (2025-2030)
Table 62. Global Pulmonary Administration Sales Market Share by Application (2019-2024)
Table 63. Global Pulmonary Administration Sales Market Share by Application (2025-2030)
Table 64. Global Pulmonary Administration Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Pulmonary Administration Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Pulmonary Administration Revenue Market Share by Application (2019-2024)
Table 67. Global Pulmonary Administration Revenue Market Share by Application (2025-2030)
Table 68. Global Pulmonary Administration Price (US$/Unit) by Application (2019-2024)
Table 69. Global Pulmonary Administration Price (US$/Unit) by Application (2025-2030)
Table 70. Aptar Pharma Company Information
Table 71. Aptar Pharma Description and Business Overview
Table 72. Aptar Pharma Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Aptar Pharma Pulmonary Administration Product
Table 74. Aptar Pharma Recent Developments/Updates
Table 75. Nemera Company Information
Table 76. Nemera Description and Business Overview
Table 77. Nemera Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Nemera Pulmonary Administration Product
Table 79. Nemera Recent Developments/Updates
Table 80. Porex Company Information
Table 81. Porex Description and Business Overview
Table 82. Porex Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Porex Pulmonary Administration Product
Table 84. Porex Recent Developments/Updates
Table 85. Chiesi Farmaceutici Company Information
Table 86. Chiesi Farmaceutici Description and Business Overview
Table 87. Chiesi Farmaceutici Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Chiesi Farmaceutici Pulmonary Administration Product
Table 89. Chiesi Farmaceutici Recent Developments/Updates
Table 90. AstraZeneca Company Information
Table 91. AstraZeneca Description and Business Overview
Table 92. AstraZeneca Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. AstraZeneca Pulmonary Administration Product
Table 94. AstraZeneca Recent Developments/Updates
Table 95. H&T Presspart Company Information
Table 96. H&T Presspart Description and Business Overview
Table 97. H&T Presspart Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. H&T Presspart Pulmonary Administration Product
Table 99. H&T Presspart Recent Developments/Updates
Table 100. Gerresheimer Company Information
Table 101. Gerresheimer Description and Business Overview
Table 102. Gerresheimer Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Gerresheimer Pulmonary Administration Product
Table 104. Gerresheimer Recent Developments/Updates
Table 105. Merxin Ltd Company Information
Table 106. Merxin Ltd Description and Business Overview
Table 107. Merxin Ltd Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Merxin Ltd Pulmonary Administration Product
Table 109. Merxin Ltd Recent Developments/Updates
Table 110. 3M Company Information
Table 111. 3M Description and Business Overview
Table 112. 3M Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. 3M Pulmonary Administration Product
Table 114. 3M Recent Developments/Updates
Table 115. Aerogen Pharma Company Information
Table 116. Aerogen Pharma Description and Business Overview
Table 117. Aerogen Pharma Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Aerogen Pharma Pulmonary Administration Product
Table 119. Aerogen Pharma Recent Developments/Updates
Table 120. MedPharm Company Information
Table 121. MedPharm Description and Business Overview
Table 122. MedPharm Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. MedPharm Pulmonary Administration Product
Table 124. MedPharm Recent Developments/Updates
Table 125. Kindeva Drug Delivery Company Information
Table 126. Kindeva Drug Delivery Description and Business Overview
Table 127. Kindeva Drug Delivery Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Kindeva Drug Delivery Pulmonary Administration Product
Table 129. Kindeva Drug Delivery Recent Developments/Updates
Table 130. Boehringer Ingelheim Company Information
Table 131. Boehringer Ingelheim Description and Business Overview
Table 132. Boehringer Ingelheim Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Boehringer Ingelheim Pulmonary Administration Product
Table 134. Boehringer Ingelheim Recent Developments/Updates
Table 135. Chiesi Farmaceutici SpA Company Information
Table 136. Chiesi Farmaceutici SpA Description and Business Overview
Table 137. Chiesi Farmaceutici SpA Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Chiesi Farmaceutici SpA Pulmonary Administration Product
Table 139. Chiesi Farmaceutici SpA Recent Developments/Updates
Table 140. Merck & Co, Inc Company Information
Table 141. Merck & Co, Inc Description and Business Overview
Table 142. Merck & Co, Inc Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Merck & Co, Inc Pulmonary Administration Product
Table 144. Merck & Co, Inc Recent Developments/Updates
Table 145. Novartis AG Company Information
Table 146. Novartis AG Description and Business Overview
Table 147. Novartis AG Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Novartis AG Pulmonary Administration Product
Table 149. Novartis AG Recent Developments/Updates
Table 150. PARI international Company Information
Table 151. PARI international Description and Business Overview
Table 152. PARI international Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. PARI international Pulmonary Administration Product
Table 154. PARI international Recent Developments/Updates
Table 155. Vectura Group Plc Company Information
Table 156. Vectura Group Plc Description and Business Overview
Table 157. Vectura Group Plc Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Vectura Group Plc Pulmonary Administration Product
Table 159. Vectura Group Plc Recent Developments/Updates
Table 160. GlaxoSmithKline Company Information
Table 161. GlaxoSmithKline Description and Business Overview
Table 162. GlaxoSmithKline Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. GlaxoSmithKline Pulmonary Administration Product
Table 164. GlaxoSmithKline Recent Developments/Updates
Table 165. Koninklijke Philips NV Company Information
Table 166. Koninklijke Philips NV Description and Business Overview
Table 167. Koninklijke Philips NV Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. Koninklijke Philips NV Pulmonary Administration Product
Table 169. Koninklijke Philips NV Recent Developments/Updates
Table 170. OMRON Corporation Company Information
Table 171. OMRON Corporation Description and Business Overview
Table 172. OMRON Corporation Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 173. OMRON Corporation Pulmonary Administration Product
Table 174. OMRON Corporation Recent Developments/Updates
Table 175. Sunovion Pharmaceuticals, Inc Company Information
Table 176. Sunovion Pharmaceuticals, Inc Description and Business Overview
Table 177. Sunovion Pharmaceuticals, Inc Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 178. Sunovion Pharmaceuticals, Inc Pulmonary Administration Product
Table 179. Sunovion Pharmaceuticals, Inc Recent Developments/Updates
Table 180. Teva Pharmaceutical Industries Ltd Company Information
Table 181. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 182. Teva Pharmaceutical Industries Ltd Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 183. Teva Pharmaceutical Industries Ltd Pulmonary Administration Product
Table 184. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 185. Yisuo Intelligent Company Information
Table 186. Yisuo Intelligent Description and Business Overview
Table 187. Yisuo Intelligent Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 188. Yisuo Intelligent Pulmonary Administration Product
Table 189. Yisuo Intelligent Recent Developments/Updates
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Pulmonary Administration Distributors List
Table 193. Pulmonary Administration Customers List
Table 194. Pulmonary Administration Market Trends
Table 195. Pulmonary Administration Market Drivers
Table 196. Pulmonary Administration Market Challenges
Table 197. Pulmonary Administration Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
Table 201. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pulmonary Administration
Figure 2. Global Pulmonary Administration Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pulmonary Administration Market Share by Type: 2023 & 2030
Figure 4. Pressurized Metered Dose Inhalation System Product Picture
Figure 5. Dry Powder Inhalation System Product Picture
Figure 6. Soft Mist Inhalation System Product Picture
Figure 7. Others Product Picture
Figure 8. Global Pulmonary Administration Market Value by Application (2024-2030) & (US$ Million)
Figure 9. Global Pulmonary Administration Market Share by Application: 2023 & 2030
Figure 10. Bronchial Asthma
Figure 11. Chronic Obstructive Pulmonary Disease
Figure 12. Others
Figure 13. Global Pulmonary Administration Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Pulmonary Administration Market Size (2019-2030) & (US$ Million)
Figure 15. Global Pulmonary Administration Sales (2019-2030) & (K Units)
Figure 16. Global Pulmonary Administration Average Price (US$/Unit) & (2019-2030)
Figure 17. Pulmonary Administration Report Years Considered
Figure 18. Pulmonary Administration Sales Share by Manufacturers in 2023
Figure 19. Global Pulmonary Administration Revenue Share by Manufacturers in 2023
Figure 20. Global 5 and 10 Largest Pulmonary Administration Players: Market Share by Revenue in Pulmonary Administration in 2023
Figure 21. Pulmonary Administration Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 22. Global Pulmonary Administration Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Pulmonary Administration Sales Market Share by Country (2019-2030)
Figure 24. North America Pulmonary Administration Revenue Market Share by Country (2019-2030)
Figure 25. United States Pulmonary Administration Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Pulmonary Administration Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Pulmonary Administration Sales Market Share by Country (2019-2030)
Figure 28. Europe Pulmonary Administration Revenue Market Share by Country (2019-2030)
Figure 29. Germany Pulmonary Administration Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Pulmonary Administration Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Pulmonary Administration Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Pulmonary Administration Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Pulmonary Administration Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Pulmonary Administration Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Pulmonary Administration Revenue Market Share by Region (2019-2030)
Figure 36. China Pulmonary Administration Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Pulmonary Administration Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Pulmonary Administration Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Pulmonary Administration Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Pulmonary Administration Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Pulmonary Administration Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Pulmonary Administration Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Pulmonary Administration Sales Market Share by Country (2019-2030)
Figure 44. Mexico Pulmonary Administration Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Pulmonary Administration Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Pulmonary Administration Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Colombia Pulmonary Administration Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East and Africa Pulmonary Administration Sales Market Share by Country (2019-2030)
Figure 49. Middle East and Africa Pulmonary Administration Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Pulmonary Administration Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Pulmonary Administration Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Pulmonary Administration Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Pulmonary Administration by Type (2019-2030)
Figure 54. Global Revenue Market Share of Pulmonary Administration by Type (2019-2030)
Figure 55. Global Pulmonary Administration Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Pulmonary Administration by Application (2019-2030)
Figure 57. Global Revenue Market Share of Pulmonary Administration by Application (2019-2030)
Figure 58. Global Pulmonary Administration Price (US$/Unit) by Application (2019-2030)
Figure 59. Pulmonary Administration Value Chain
Figure 60. Pulmonary Administration Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
